Women's Health Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Assisted Reproduction
Mifepristone prevents premature LH surges in women undergoing COH for IVF
June 2nd, 2005
"Mifepristone is effective for the prevention premature luteinizing hormone (LH) surges and/or premature luteinization in women undergoing controlled ovarian hyperstimulation for in vitro fertilization," report specialists at a clinic in the Netherlands. E.L. Escudero and colleagues, Institute for Clinical Concept Research, Pantarhei Bioscience BV, AL Zeist, wrote, "The present clinical study was conducted to investigate the effectiveness of a daily dose of 40 mg mifepristone in preventing premature LH surges in women undergoing controlled ovarian hyperstimulation (COH) for in vitro fertilization (IVF) and to study the effect of this antiprogestin cotreatment on...
Source: Women's Health Weekly (2005-06-02)
|
